Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest levels seen in more than three ...

The World Health Organization (WHO) has officially recommended the global rollout of injectable lenacapavir (LEN), a ...

For children with congenital deafness from OTOF mutations, gene therapy is now restoring hearing — without surgery or ...

WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV ...

Politics and anxiety drive Part One, subtitled “Millennium Approaches,” and Part Two, “Perestroika,” diverges into the ...

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for ...

Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S.

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?